Biocryst Pharmaceuticals reported $23.38M in Stock for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alnylam Pharmaceuticals ALNY:US USD 115.49M 26.51M
Chugai Pharma 4519:JP JPY 313.02B 94.55B
Daiichi Sankyo 4568:JP JPY 262.13B 12.82B
Gilead Sciences GILD:US USD 2.6B 15M
GlaxoSmithKline GSK:LN GBP 4.66B 5M
Intra Cellular Therapies ITCI:US USD 23.6M 1.42M
IONIS PHARMACEUT IONS:US USD 20.64M 834K
Karyopharm Therapeutics KPTI:US USD 4.25M 779K
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Novavax NVAX:US USD 82.43M 173.87M
Ptc Therapeutics PTCT:US USD 14.81M 192K
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Roche Holding ROG:VX 8.29B 577M
Sarepta Therapeutics SRPT:US USD 221.19M 13.1M
Ultragenyx Pharmaceutical RARE:US USD 21.85M 770K
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M
YTE INCY:US USD 45.87M 8.63M